{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:53:19Z","timestamp":1793332399145,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68227-8","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:38:47Z","timestamp":1722530327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Sodium butyrate improves renal injury in diabetic nephropathy through AMPK\/SIRT1\/PGC-1\u03b1 signaling pathway"],"prefix":"10.1038","volume":"14","author":[{"given":"Kaili","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"issue":"2","key":"68227_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. J. Nat. Rev. Endocrinol. 14(2), 88\u201398 (2018).","journal-title":"J. Nat. Rev. Endocrinol."},{"key":"68227_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. J. Diabetes Res. Clin. Pract. 157, 107843 (2019).","journal-title":"J. Diabetes Res. Clin. Pract."},{"issue":"2","key":"68227_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12192-020-01176-z","volume":"26","author":"P Victor","year":"2021","unstructured":"Victor, P. et al. Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathy. J. Cell Stress Chaperones 26(2), 311\u2013321 (2021).","journal-title":"J. Cell Stress Chaperones"},{"issue":"7","key":"68227_CR4","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.bbadis.2018.09.032","volume":"185","author":"R Fernandes","year":"2019","unstructured":"Fernandes, R. et al. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy. J. Biochim. Biophys. Acta Mol. Basis Dis. 185(7), 1876\u20131897 (2019).","journal-title":"J. Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"68227_CR5","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu, N. Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. J. Biomed Res. Int. 2021, 1497449 (2021).","journal-title":"J. Biomed Res. Int."},{"key":"68227_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-017-0183-1","volume":"7","author":"M He","year":"2017","unstructured":"He, M. & Shi, B. Gut microbiota as a potential target of metabolic syndrome: The role of probiotics and prebiotics. Cell Biosci. 7, 54 (2017).","journal-title":"Cell Biosci."},{"issue":"7","key":"68227_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","volume":"14","author":"Y Tao","year":"2018","unstructured":"Tao, Y. et al. The gut microbiota and the brain\u2013gut\u2013kidney axis in hypertension and chronic kidney disease. J. Nat. Rev. Nephrol. 14(7), 442\u2013456 (2018).","journal-title":"J. Nat. Rev. Nephrol."},{"issue":"8","key":"68227_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134311","volume":"10","author":"C Barrios","year":"2015","unstructured":"Barrios, C. et al. Gut\u2013microbiota\u2013metabolite axis in early renal function decline. PLoS\u00a0One 10(8), e0134311 (2015).","journal-title":"PLoS\u00a0One"},{"issue":"3","key":"68227_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11892-017-0841-z","volume":"17","author":"A Sabatino","year":"2017","unstructured":"Sabatino, A. et al. Intestinal microbiota in type 2 diabetes and chronic kidney disease. J. Curr. Diabetes Rep. 17(3), 16 (2017).","journal-title":"J. Curr. Diabetes Rep."},{"key":"68227_CR10","volume":"2020","author":"W Huang","year":"2020","unstructured":"Huang, W. et al. Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-kappaB signaling. J. Oxid. Med. Cell. Longev. 2020, 4074832 (2020).","journal-title":"J. Oxid. Med. Cell. Longev."},{"issue":"2","key":"68227_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nm.3779","volume":"21","author":"C Tang","year":"2015","unstructured":"Tang, C. et al. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. J. Nat. Med. 21(2), 173\u2013177 (2015).","journal-title":"J. Nat. Med."},{"issue":"3","key":"68227_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison, D. J. & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7(3), 189\u2013200 (2016).","journal-title":"Gut Microbes"},{"issue":"27","key":"68227_CR13","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.1021\/acs.jafc.9b02083","volume":"67","author":"WQ Zhang","year":"2019","unstructured":"Zhang, W. Q. et al. Sodium butyrate improves liver glycogen metabolism in type 2 diabetes mellitus. J. Agric. Food Chem. 67(27), 7694\u20137705 (2019).","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"68227_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1530\/JOE-16-0322","volume":"232","author":"W Dong","year":"2017","unstructured":"Dong, W. et al. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC. J. Endocrinol. 232(1), 71\u201383 (2017).","journal-title":"J. Endocrinol."},{"issue":"10","key":"68227_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14334","volume":"46","author":"X Tang","year":"2022","unstructured":"Tang, X. et al. Sodium butyrate protects against oxidative stress in high-fat-diet-induced obese rats by promoting GSK-3beta\/Nrf2 signaling pathway and mitochondrial function. J. Food Biochem. 46(10), e14334 (2022).","journal-title":"J. Food Biochem."},{"issue":"2","key":"68227_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009085","volume":"5","author":"N Larsen","year":"2010","unstructured":"Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS\u00a0One 5(2), e9085 (2010).","journal-title":"PLoS\u00a0One"},{"key":"68227_CR17","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.2147\/DMSO.S320169","volume":"14","author":"C Weihong","year":"2021","unstructured":"Weihong, C. et al. The profile and function of gut microbiota in diabetic nephropathy. J. Diabetes Metab. Syndr. Obes. 14, 4283\u20134296 (2021).","journal-title":"J. Diabetes Metab. Syndr. Obes."},{"issue":"5","key":"68227_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41401-019-0330-9","volume":"41","author":"PP Zhang","year":"2020","unstructured":"Zhang, P. P. et al. Fecal microbiota transplantation improves metabolism and gut microbiome composition in db\/db mice. J. Acta Pharmacol. Sin. 41(5), 678\u2013685 (2020).","journal-title":"J. Acta Pharmacol. Sin."},{"issue":"4","key":"68227_CR19","first-page":"913","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. J. Gastroenterol. 143(4), 913-916 e7 (2012).","journal-title":"J. Gastroenterol."},{"issue":"3","key":"68227_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1530\/JOE-18-0137","volume":"238","author":"YH Xu","year":"2018","unstructured":"Xu, Y. H. et al. Sodium butyrate supplementation ameliorates diabetic inflammation in db\/db mice. J. Endocrinol. 238(3), 231\u2013244 (2018).","journal-title":"J. Endocrinol."},{"issue":"4","key":"68227_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker, D. J. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 27(4), 740\u2013756 (2018).","journal-title":"Cell Metab."},{"issue":"11","key":"68227_CR22","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2337\/db11-1824","volume":"61","author":"A Mima","year":"2012","unstructured":"Mima, A. et al. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCbeta activation in diabetes. J. Diabetes 61(11), 2967\u20132979 (2012).","journal-title":"J. Diabetes"},{"key":"68227_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.ijbiomac.2019.03.242","volume":"132","author":"Y Feng","year":"2019","unstructured":"Feng, Y. et al. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice. Int. J. Biol. Macromol. 132, 1001\u20131011 (2019).","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"68227_CR24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ijo.2015.84","volume":"39","author":"CS Byrne","year":"2015","unstructured":"Byrne, C. S. et al. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. (Lond) 39(9), 1331\u20131338 (2015).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"11","key":"68227_CR25","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.2337\/db15-0481","volume":"64","author":"S Forbes","year":"2015","unstructured":"Forbes, S. et al. Selective FFA2 agonism appears to act via intestinal PYY to reduce transit and food intake but does not improve glucose tolerance in mouse models. J. Diabetes 64(11), 3763\u20133771 (2015).","journal-title":"J. Diabetes"},{"issue":"2","key":"68227_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/oby.20501","volume":"22","author":"K Vidrine","year":"2014","unstructured":"Vidrine, K. et al. Resistant starch from high amylose maize (HAM-RS2) and dietary butyrate reduce abdominal fat by a different apparent mechanism. Obesity (Silver Spring, MD) 22(2), 344\u2013348 (2014).","journal-title":"Obesity (Silver Spring, MD)"},{"issue":"4","key":"68227_CR27","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1039\/C8FO02265H","volume":"10","author":"K Li","year":"2019","unstructured":"Li, K. et al. Dietary inulin alleviates diverse stages of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in db\/db mice. Food Funct. 10(4), 1915\u20131927 (2019).","journal-title":"Food Funct."},{"issue":"8","key":"68227_CR28","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1096\/fj.202000431R","volume":"34","author":"Y Du","year":"2020","unstructured":"Du, Y. et al. Butyrate alleviates diabetic kidney disease by mediating the miR-7a-5p\/P311\/TGF-beta1 pathway. FASEB J. 34(8), 10462\u201310475 (2020).","journal-title":"FASEB J."},{"issue":"2","key":"68227_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1055\/s-0042-121493","volume":"125","author":"W Huang","year":"2017","unstructured":"Huang, W. et al. Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide. Exp. Clin. Endocrinol. Diabetes 125(2), 98\u2013105 (2017).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1\u20132","key":"68227_CR30","first-page":"1","volume":"100","author":"X Ren","year":"2017","unstructured":"Ren, X. et al. Influence of dipeptidyl peptidase-IV inhibitor sitagliptin on extracellular signal-regulated kinases 1\/2 signaling in rats with diabetic nephropathy. J. Pharmacol. 100(1\u20132), 1\u201313 (2017).","journal-title":"J. Pharmacol."},{"issue":"5","key":"68227_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41424-018-0025-4","volume":"9","author":"K Bouter","year":"2018","unstructured":"Bouter, K. et al. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects. Clin. Transl. Gastroenterol. 9(5), 155 (2018).","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"6","key":"68227_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.612","volume":"7","author":"S Zhai","year":"2018","unstructured":"Zhai, S. et al. Effect of lactulose intervention on gut microbiota and short chain fatty acid composition of C57BL\/6J mice. Microbiol. Open 7(6), e00612 (2018).","journal-title":"Microbiol. Open"},{"key":"68227_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnx075","author":"L Zhu","year":"2017","unstructured":"Zhu, L. et al. Inulin with different degrees of polymerization modulates composition of intestinal microbiota in mice. FEMS Microbiol. Lett. https:\/\/doi.org\/10.1093\/femsle\/fnx075 (2017).","journal-title":"FEMS Microbiol. Lett."},{"issue":"13","key":"68227_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnz153","volume":"366","author":"S Zhai","year":"2019","unstructured":"Zhai, S. et al. Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice. FEMS Microbiol. Lett. 366(13), fnz153 (2019).","journal-title":"FEMS Microbiol. Lett."},{"issue":"1","key":"68227_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. J. Nat. Med. 21(1), 37\u201346 (2015).","journal-title":"J. Nat. Med."},{"issue":"6","key":"68227_CR36","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nm.4328","volume":"23","author":"W Qi","year":"2017","unstructured":"Qi, W. et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. J. Nat. Med. 23(6), 753\u2013762 (2017).","journal-title":"J. Nat. Med."},{"issue":"8","key":"68227_CR37","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/1873-3468.14077","volume":"595","author":"NMB Yapa","year":"2021","unstructured":"Yapa, N. M. B. et al. Mitochondrial dynamics in health and disease. FEBS Lett. 595(8), 1184\u20131204 (2021).","journal-title":"FEBS Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68227-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:43:17Z","timestamp":1722530597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68227-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68227-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3875121\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17867"}}